Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling - sprookjes - yvandenbroek - TriplyDB

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling

http://www.wikidata.org/entity/Q33632245

about

Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer Mouse Models in Prostate Cancer Translational Research: From Xenograft to PDX Androgen receptor mutations and polymorphisms in African American prostate cancer.Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT.Androgen receptor signaling and mutations in prostate cancer Androgen Receptor-Mediated Growth Suppression of HPr-1AR and PC3-Lenti-AR Prostate Epithelial Cells.The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor Genetic and epigenetic changes in human prostate cancer Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.Cell line modeling to study biomarker panel in prostate cancer.Low p16INK4a Expression in Early Passage Human Prostate Basal Epithelial Cells Enables Immortalization by Telomerase Expression Alone.Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.Adaptive auto-regulation of androgen receptor provides a paradigm shifting rationale for bipolar androgen therapy (BAT) for castrate resistant human prostate cancer.Human prostate cancer initiating cells isolated directly from localized cancer do not form prostaspheres in primary culture.Supraphysiologic Testosterone Therapy in the Treatment of Prostate Cancer: Models, Mechanisms and Questions.Hypothalamic expression of oestrogen receptor α and androgen receptor is sex-, age- and region-dependent in mice.Resolving the Coffey Paradox: what does the androgen receptor do in normal vs. malignant prostate epithelial cells?Mouse models of prostate cancer

P2860

Q21091046-DEFFB42A-F117-4F6A-9862-0A6AB14D00EE Q24633279-5AC88EB0-FB2D-436C-B456-2A7B78CB70A7 Q26746524-15A0F43D-7CBA-4203-ADAC-F96B2F9C1923 Q33775730-E5FFF467-BB1A-4406-A82C-5E1E15AFAAE2 Q33970160-D190D7E9-732B-4A82-917B-C2FD243BFC2A Q34425907-40772D53-03D2-4045-8874-54D88C3E7ADD Q35776234-83F2C0B4-E939-456E-8B02-621CEB063C45 Q35838409-1D101647-D159-4C2A-980A-5A528AD3C8A3 Q36022274-4BC37CCB-FE50-48B1-9FB4-9BC95C997A5A Q36067956-9BD57DF6-D6DF-4C4F-A438-EDF69D22A4C2 Q36867637-985286C9-7315-46BB-A450-9B255617A06A Q38382669-5F63416A-17DC-40DE-8D82-50F4CD135DCE Q38730507-7F0871C5-ADC9-42C5-B495-8E6A43798DEF Q38922304-303F45E7-7D0C-42E9-B814-534A5794502E Q39384179-3D55434F-8D93-4055-B908-5C264B566F0D Q39384187-66DC1941-D6AB-4A26-9B5F-13B50DAA5398 Q47359141-215279A1-6B2C-4752-8F22-D03D20519141 Q48370698-80160299-C6C2-4394-AA73-B832FD26A711 Q55315541-C0131F7B-9DF1-43E0-85F0-09157FB47D36 Q58693513-B33D2A34-8969-463E-BF00-53FCD6762D48

P2860

Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling

http://www.wikidata.org/entity/Q33632245

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Loss of androgen receptor-depe ...... to androgen receptor signaling

@ast

Loss of androgen receptor-depe ...... to androgen receptor signaling

@en

type

label

Loss of androgen receptor-depe ...... to androgen receptor signaling

@ast

Loss of androgen receptor-depe ...... to androgen receptor signaling

@en

prefLabel

Loss of androgen receptor-depe ...... to androgen receptor signaling

@ast

Loss of androgen receptor-depe ...... to androgen receptor signaling

@en

P1433

Q33632245-F935A146-09DE-4B2D-93D7-04EF3249BF7A

P1476

Q33632245-44333793-796E-4C4B-B26C-47DDB8CA38D0

P2093

Q33632245-09679A97-AFB0-4D14-BEA8-7343458C8F69

Q33632245-7491C893-34C0-45A9-8E29-589CB952DC42

Q33632245-950CAC4D-F603-4020-916F-9E2B615DDB65

Q33632245-9F889FC5-D431-4888-B298-D4A5F6147384

Q33632245-B90452EC-4F1B-411D-80D9-2665B443FB8C

Q33632245-CEF2A8FD-89ED-4D02-8AE0-84FDB6CA508C

Q33632245-E68FDA4C-DBB0-40CE-A644-C6358428A410

P2860

Q33632245-0AA4A61B-C64F-4A94-AB4D-8BB9B829ACE3

Q33632245-13CDD862-DB17-4E4F-ADD2-BBE8CD2E9907

Q33632245-32D59036-33A8-4A3F-A552-E019BCF6E5C6

Q33632245-33340485-2314-40CD-8B15-624C19D88DE5

Q33632245-3F9126CB-083B-4E2E-85E1-CB676479C1EC

Q33632245-43908CEC-52D7-493A-A9C3-D5964B2A67D8

Q33632245-472867CA-41C5-4EC1-898C-99D41EF8AD4C

Q33632245-49366391-CDF8-4F79-AC10-910B229AD32D

Q33632245-4B47AB36-D97B-4426-8F0E-F8E700BA4E74

Q33632245-4BF7F35F-7DFC-410F-A9E2-6A47322ED218

P304

Q33632245-DC88191B-B046-4DDB-9B87-5714E69D7EB3

P31

Q33632245-D2734C84-1B10-440E-9631-4ACFEB3F09F4

P356

Q33632245-A7063F48-ED7C-460A-BF77-E5D76D2C656E

P407

Q33632245-3434CD2D-9590-4CD1-94B7-A3FEB20C3F37

P433

Q33632245-6EE9708F-87B2-4760-9718-67393E135C64

P478

Q33632245-57B3D363-CD6A-4D6A-8C6B-7303D8C38FBD

P577

Q33632245-4F8F7C2E-0C68-489F-AA77-FAE242ED3C1F

P5875

Q33632245-E89A682A-4087-4436-900C-DB0347A4EBC8

P698

Q33632245-5E999911-2813-4BF7-B8E6-2F0B6055B9D7

P932

Q33632245-30CC9959-535D-42E4-9FCE-DB7A4A26B0D5

P356

JOURNAL.PONE.0011475

P1433

P1476

Loss of androgen receptor-depe ...... to androgen receptor signaling

@en

P2093

Donald J Vander Griend

http://www.w3.org/2001/XMLSchema#string

George Ndikuyeze

http://www.w3.org/2001/XMLSchema#string

Jason M D'Antonio

http://www.w3.org/2001/XMLSchema#string

John T Isaacs

http://www.w3.org/2001/XMLSchema#string

Lizamma Antony

http://www.w3.org/2001/XMLSchema#string

Shahriar Koochekpour

http://www.w3.org/2001/XMLSchema#string

Susan L Dalrymple

http://www.w3.org/2001/XMLSchema#string

P2860

A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival

Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA

Disorders linked to insufficient androgen action in male children

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells

Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor

Disruption of prostate epithelial androgen receptor impedes prostate lobe-specific growth and function

Loss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.

A history of prostate cancer treatment

Molecular characterization of human prostate carcinoma cell lines.

P304

e11475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0011475

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45185845

http://www.w3.org/2001/XMLSchema#string

P698

20628607

http://www.w3.org/2001/XMLSchema#string

P932

2900211

http://www.w3.org/2001/XMLSchema#string